Considerations on the Construction, Timing, and Consequences of the Psychedelic Renaissance
Cindy Brooks Dollar
Contemporary Drug Problems June 9, 2025 DOI: 10.1177/00914509251344637 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Key points | Argues that the revitalization of US psychedelic science, framed by media as a psychedelic renaissance, is intertwined with the national opiate crisis and that institutional cynicism may explain why clinically oriented research has often ignored marginalized populations, reinforcing criminalization of their nonmedical use and the medicalization-criminalization divide. |
Abstract
Institutionally supported studies on psychedelic use are growing tremendously in the United States, leading US mass media outlets to declare a psychedelic renaissance. Interestingly, national survey data also indicate increases in nonmedical psychedelic use. Largely due to the reinstatement of system-supported psychedelic experiments, the dominant cultural narrative of psychedelic use today contrasts sharply with that of the late 1960s when psychedelic possession and consumption underwent staunch criminalization efforts. This interpretative essay interrogates the revitalization of psychedelic science in the United States by raising questions and hypothesizations about the construction, timing, and consequences of the so-called second wave of psychedelic science. In doing so, I highlight the media's framing of a psychedelic renaissance, the timing of institutionally supported psychedelic science research as it relates to the national opiate crisis, and subsequent increases in nonmedical psychedelic ingestion among the general US public and specific marginalized groups. In clarifying the latter, I argue that institutional cynicism may explain why clinically oriented psychedelic science has and often continues to ignore marginalized populations. In doing so, criminalization efforts against their nonmedical (i.e., self-directed) psychedelic users are reinforced as is the medicalization–criminalization divide.
Citations in the library
Cites 50
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
- Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin Proceedings of the National Academy of Sciences January 23, 2012
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study Journal of Psychopharmacology January 13, 2015
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Psychopharmacology December 1, 2011
and 45 more in the library